β2-Adrenergic Receptor Haplotype may be Associated with Susceptibility to Desensitization to Long-Acting β2-Agonists in COPD Patients
- 13 April 2012
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 190 (4) , 411-417
Abstract
Τhat β2-adrenergic receptor (β2AR) haplotypes may play a key role in clinical response to β2-agonists and haplotype Cys-19Gly16Gln27 (CysGlyGln) is reported to be associated with desensitization of β2AR to β-agonists in lymphocytes isolated from patients with asthma and septic shock. We sought to determine whether haplotypic variation of the β2AR affects the functional outcomes of long-acting β2-agonist (LABA) treatment for chronic obstructive pulmonary disease (COPD) when used as monotherapy. Treatment-naïve patients with COPD (n = 36) were prospectively treated with two kinds of LABA—inhaled salmeterol and transdermal tulobuterol patch—for 12 weeks in crossover study, and changes in pulmonary function data and 6-minute walk distance (6MWD) were compared between groups stratified by the CysGlyGln. Frequencies of haplotype and diplotype for the CysGlyGln were 0.51 and 0.36, respectively. The individuals homozygous for CysGlyGln showed less improvement in FEV1, %FEF25−75 %, and IC/TLC than those with 0 or 1 copy of CysGlyGln after treatment with both LABAs despite initial bronchodilator responses to albuterol being similar in these groups. The response in these parameters was not significantly different between two types of LABA. Overall changes in 6MWD in individuals with 2 copies of CysGlyGln versus 0 or 1 copy for salmeterol were 2.8 and 11 m, and for tulobuterol were −1.3 and 16 m, respectively. Homozygous haplotype for the CysGlyGln of β2AR may be associated with susceptibility to desensitization to LABA in patients with COPD.Keywords
This publication has 25 references indexed in Scilit:
- β2‐adrenoceptor agonists: current and future directionBritish Journal of Pharmacology, 2011
- Common ADRB2 Haplotypes Derived from 26 Polymorphic Sites Direct β2-Adrenergic Receptor Expression and Regulation PhenotypesPLOS ONE, 2010
- Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trialThe Lancet, 2009
- COMPARISON OF ADHERENCE AND EFFICACY BETWEEN INHALED SALMETEROL AND TRANSDERMAL TULOBUTEROL PATCH IN ELDERLY PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISORDERJournal of the American Geriatrics Society, 2009
- β-Adrenergic receptor polymorphisms: relationship to the β-agonist controversy and clinical implicationsExpert Opinion on Pharmacotherapy, 2007
- Influence of β2‐adrenoceptor gene polymorphisms on β2‐adrenoceptor‐mediated responses in human lung mast cellsBritish Journal of Pharmacology, 2007
- Sequence, Haplotype, and Association Analysis of ADRβ2 in a Multiethnic Asthma Case-Control StudyAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthmaJournal of Allergy and Clinical Immunology, 2006
- Family-based association analysis of β2-adrenergic receptor polymorphisms in the childhood asthma management programJournal of Allergy and Clinical Immunology, 2003
- The Effect of Common Polymorphisms of the β2-Adrenergic Receptor on Agonist-Mediated Vascular DesensitizationNew England Journal of Medicine, 2001